CDKN1B and neoplasm: Altogether, the work from Francis et al. not only confirmed the previous findings but also found new heterozygous frameshift mutations in CDKN1B, strengthening the notion that this gene acts as a haploinsufficient tumor-suppressor in SI-NETs.